Pharmaceuticals

Dr Reddys shows steady Q1 performance

23 Jul 2010

Number of older people with HIV up by 60 per cent in UK

22 Jul 2010

Reckitt Benckiser to acquire SSL International for €2.54 billion

21 Jul 2010

Bayer Schering Pharma in research pact with China's largest military hospital

20 Jul 2010

US FDA warns against steroidal 'dietary supplements' sold on-line

19 Jul 2010

Taro mulls next move after dismissal of US suit against Sun Pharma

17 Jul 2010

Sun Pharma announces US FDA approval for generic Flomax

16 Jul 2010

Aspen takeover plan hits snags as Sigma cuts 2011 guidance

16 Jul 2010

Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business

15 Jul 2010

FDA wants GSK to add more health warnings on diabetese drug Avandia

15 Jul 2010

GlaxoSmithKline: truth is a bitter pill

14 Jul 2010

Government plans Rs10,000-crore VC fund for drug research

13 Jul 2010

The fund, to be set up as an independent asset management company under the PPP model, will have 15 per cent government participation while the rest will come from other investors.

J&J to buy stroke specialist Micrus Endovascular for $480 million

13 Jul 2010

Jubilant Organosys to hive off non-pharma biz, amalgamate other units

08 Jul 2010

Aspen lowers takeover offer for Sigma by 8.3 per cent

08 Jul 2010

AstraZeneca scrip slumps after buy-back offer

07 Jul 2010

Sanofi-Aventis gearing to make US acquisition worth $20 billion: report

03 Jul 2010

Hyderabad-based Aptuit Laurus's parent to acquire GSK's Verona research operations

02 Jul 2010

Sun Pharma gains 180-day marketing exclusivity for generic Exelon in the US

02 Jul 2010

Celgene Corporation to buy Abraxis BioScience for $2.9 billion

30 Jun 2010

Sanofi-Aventis to buy US oncology products firm TargeGen for $560 million

30 Jun 2010

Abbott to hive off flu vaccine business of Solvay: report

29 Jun 2010

New inhalable measles vaccine may lead to vaccines for other diseases

29 Jun 2010

A dry powder, inhalable vaccine developed for measles prevention and slated for human clinical trials later this year in India will lead to other inhalable, inexpensive vaccines for a range of illnesses.

Pharmaceutical companies cut down on R&D, push sales of old drugs: report

28 Jun 2010

Myanmar destroys illicit drugs worth $76 million

26 Jun 2010